Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae

References

1. Alouf J. E. 1980; Streptococcal toxins (streptolysin O, Streptolysin S, erythrogenic toxin). Pharmacology and Therapeutics 11:661–717
   [Google Scholar]
2. Andersson B., Eriksson B., Falsen E., Fogh A., Hanson L. A., Nylen O., Peterson H., Svanborg-Eden C. 1981; Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infection and Immunity 32:311–317
   [Google Scholar]
3. Andersson B., Dahmen J., Frejd T., Leffler H., Magnusson G., Noori G., Eden C. S. 1983; Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human epithelial cells. Journal of Experimental Medicine 158:559–570
   [Google Scholar]
4. Andersson B., Beachey E. H., Tomasz A., Tuomanen E., Svanborg-Eden C. 1988; A sandwich adhesin on Streptococcus pneumoniae attaching to oropharyngeal epithelial cells in vitro. Microbial Pathogenesis 4:267–268
   [Google Scholar]
5. Austrian R. 1982a Pneumococcus: the first one hundred years. In The Pneumococcus and the Pneumococcus Vaccine, pp. 1–7 Edited by Quie P. G., Kass E. H. Chicago: University of Chicago Press;
   [Google Scholar]
6. Austrian R. 1982b Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. In The Pneumococcus and the Pneumococcal Vaccine, pp. 191–207 Edited by Quie P. G., Kass E. H. Chicago: University of Chicago Press;
   [Google Scholar]
7. Austrian R. 1986; Some aspects of the pneumococcal carrier state. Journal of Antimicrobial Chemotherapy 18:35–45
   [Google Scholar]
8. Austrian R., Howie V. M., Ploussard J. H. 1977; The bacteriology of pneumococcal otitis media. Johns Hopkins Medical Journal 141:104–111
   [Google Scholar]
9. Berry A. M., Paton J. C, Glare D., Hansman D., Catcheside D. E. A. 1988; Cloning and expression of the pneumococcal neuraminidase in Escherichia coli. Gene 71:199–305
   [Google Scholar]
10. Berry A. M, Lock R. A., Hansman D., Paton J. C. 1989a; Contribution of autolysin to virulence of Streptococcus pneumoniae. Infection and Immunity 57:2324–2330
    [Google Scholar]
11. Berry A. M., Yother J., Briles D. E., Hansman D., Paton J. C. 1989b; Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infection and Immunity 57:2037–2042
    [Google Scholar]
12. Bhakdi S., Tranum-Jensen J. 1985; Complement activation and attack on autologous cells induced by streptolysin-O. Infection and Immunity 48:713–719
    [Google Scholar]
13. Bhakdi S., Tranum-Jensen J. 1987; Damage to mammalian cells by proteins that form transmembrane pores. Reviews of Physiology, Biochemistry and Pharmacology 107:147–223
    [Google Scholar]
14. Bhakdi S., Tranum-Jensen J. 1988; Damage to cell membranes by pore-forming bacterial cytolysins. Progress in Allergy 40:1–43
    [Google Scholar]
15. Boulnois G. J., Mitchell T. J., Saunders F. K., Mendez F.-J., Andrew P. W. 1990 Structure and function of pneumolysin, the thiol-activated toxin of. Streptococcus pneumoniae. In Bacterial Protein Toxins, pp. 43–51 Edited by Rappuoli R. and others. Stuttgart: Gustav Fischer;
    [Google Scholar]
16. Boulnois G. J., Mitchell T. J., Saunders K., Owen R., Canvin J., Shepherd A., Camara M., Wilson R., Feldman C, Steinfort C, Bashford L, Pasternak C., Andrew P. W. 1991a Analysis of some putative protein virulence factors of. Streptococcus pneumoniae. In Genetics and Molecular Biology of Streptococci, Lactococci, and Enterococci, pp. 83–87 Edited by Dunny G. M., Cleary P. P., McKay L. L. Washington, DC: American Society for Microbiology;
    [Google Scholar]
17. Boulnois G. J., Mitchell T. J., Paton J. C., Andrew P. W. 1991b; Structure and function of pneumolysin, the multifunctional, membrane damaging toxin of Streptococcus pneumoniae. Molecular Microbiology 5:2611–2616
    [Google Scholar]
18. Briles D. E., Yother J., McDaniel L. S. 1988; Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Reviews of Infectious Diseases 10:S372–S374
    [Google Scholar]
19. Briles D. E., Forman C, Horowitz J. C, Volanakis J. E., Benjamin J. W. H., McDaniel L. S., Eldridge J., Brooks J. 1989; Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infection and Immunity 57:1457–1464
    [Google Scholar]
20. Busse W. 1991; Pathogenesis and sequelae of respiratory infections. Reviews of Infectious Diseases 13:S477–S485
    [Google Scholar]
21. Camara M., Mitchell T. J., Andrew P. W., Boulnois G. J. 1991; Streptococcus pneumoniae produces at least two distinct enzymes with neuraminidase activity: cloning and expression of a second neuraminidase gene in Escherichia coli. Infection and Immunity 59:2856–2858
    [Google Scholar]
22. Crain M. J., Waltman W. D. II Turner J. S., Yother J., Talkington D. F., McDaniel L. S., Gray B. M., Briles D. E. 1990; Pneumococcal surface protein-A (PspA) is serologically highly variable and is expressed by all clinically important serotypes of Streptococcus pneumoniae. Infection and Immunity 58:3293–3299
    [Google Scholar]
23. van Dam J. E. G., Fleer A., Snippe H. 1990; Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie van Leeuwenhoek 58:1–47
    [Google Scholar]
24. Dick T. B., Gemmell C. G. 1971; The pathogenesis of pneumococcal infection in mice. Journal of Medical Microbiology 4:153–163
    [Google Scholar]
25. Fahnestock S. R., Alexander P., Filpula D., Nagle J. 1990 Structure and evolution of the streptococcal genes encoding protein G. In Bacterial Immunoglobulin Binding Proteins, pp. 133–148 Edited by Boyle M. D. P. London: Academic Press;
    [Google Scholar]
26. Feldman C, Mitchell T. J., Andrew P. W., Boulnois G. J., Read R. C, Todd H. C, Cole P. J., Wilson R. 1990; The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microbial Pathogenesis 9:275–284
    [Google Scholar]
27. Feldman C, Munro N. C, Jeffrey R. K., Mitchell T. J., Andrew P. W., Boulnois G. J., Guerreiro D., Rohde J. A. L., Todd H. C, Cole P. J., Wilson R. 1991; Pneumolysin induces the salient histological features of pneumococcal infection in the rat lung in vivo. American Journal of Respiratory Cell and Molecular Biology 5:416–423
    [Google Scholar]
28. Ferrante A., Rowan-Kelly B., Paton J. C. 1984; Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Infection and Immunity 46:585–589
    [Google Scholar]
29. Field M. E., Shaffer M. F., Enders J. F., Drinker C. K. 1937; The distribution in the blood and lymph of pneumococcus type III injected intravenously in rabbits, and the effect of treatment with specific antiserum on the infection in lymph. Journal of Experimental Medicine 65:469–485
    [Google Scholar]
30. Geoffroy C, Gilles A.-M., Alouf J. E. 1981; The sulfhydryl groups of the thiol-dependent cytolytic toxin from Bacillus alvei: evidence for one essential sulfhydryl group. Biochemical and Biophysical Research Communications 99:781–788
    [Google Scholar]
31. Geoffroy C, Mengaud J., Alouf J. E., Cossart P. 1990; Alveolysin, the thiol-activated toxin of Bacillus alvei, is homologous to listeriolysin O, perfringolysin O, pneumolysin and streptolysin O and contains a single cysteine. Journal of Bacteriology 172:7301–7305
    [Google Scholar]
32. Green M. J., Buckley J. T. 1990; Site-directed mutagenesis of the hole-forming toxin aerolysin: Studies on the role of histidines in receptor binding and oligomerization of the monomer. Biochemistry 29:2177–2180
    [Google Scholar]
33. Greenwood B. M. 1987 Pneumococcal infection. In Oxford Textbook of Medicine, pp. 5.182–5.191 Edited by Weatherall D. J., Ledingham J. G. G., Warrell D. A. Oxford: Oxford University Press;
    [Google Scholar]
34. Guss B., Lindberg M., Uhlen M. 1990 The gene for staphylococcal protein A. In Bacterial Immunoglobulin Binding Proteins, pp. 29–39 Edited by Boyle M. D. P. London: Academic Press;
    [Google Scholar]
35. Gwaltney G. S., Sande M. A., Austrian R., Hendley J. O. 1975; Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. Journal of Infectious Diseases 132:62–68
    [Google Scholar]
36. Heffron R. 1939 Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia, p. 1086 New York: The Commonwealth Fund;
37. Horowitz J., Volanakis J. E., Briles D. E. 1987; Blood clearance of Streptococcus pneumoniae by C-reactive protein. Journal of Immunology 138:2598–2603
    [Google Scholar]
38. Humphrey J. H. 1948; Hyaluronidase production by pneumococci. Journal of Pathology and Bacteriology 55:273–275
    [Google Scholar]
39. Iwamoto M., Ohno-Iwashita Y., Ando S. 1987; Role of the essential thiol group in the thiol-activated cytolysin from Clostridium perfringens. European Journal of Biochemistry 167:425–430
    [Google Scholar]
40. Jalonen E., Paton J. C, Koskela M., Kerttula Y., Leinonen M. 1989; Measurement of antibody responses to pneumolysin - a promising method for the presumptive aetiological diagnosis of pneumococcal pneumonia. Journal of Infection 19:127–134
    [Google Scholar]
41. Johnson M. K. 1977; Cellular location of pneumolysin. FEMS Microbiology Letters 2:243–245
    [Google Scholar]
42. Johnson M. K., Knight R. J., Drew G. K. 1982; The hydrophobic character of thiol-activated cytolysins. Biochemical Journal 207:557–560
    [Google Scholar]
43. Johnston R. B. 1991; Pathogenesis of pneumococcal pneumonia. Reviews of Infectious Diseases 13:S509–S517
    [Google Scholar]
44. Kanclerski K., Blomquist S., Granstrom M., Mollby R. 1988; Serum-antibodies to pneumolysin in patients with pneumonia. Journal of Clinical Microbiology 26:96–100
    [Google Scholar]
45. Kehoe M. K., Timmis K. N. 1984; Cloning and expression in Escherichia coli of the streptolysin O determinant from Streptococcus pyogenes: characterization of the cloned streptolysin determinant and demonstration of the absence of substantial homology with determinants of other thiol-activated toxins. Infection and Immunity 43:804–810
    [Google Scholar]
46. Kehoe M. K., Miller L., Walker J. A., Boulnois G. J. 1987; Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins. Infection and Immunity 55:3228–3232
    [Google Scholar]
47. Kelly R., Greiff D. 1970; Toxicity of pneumococcal neuraminidase. Infection and Immunity 2:115–117
    [Google Scholar]
48. Kelly R. T., Farmer S., Greiff D. 1967; Neuraminidase activity of clinical isolates of Diplococcus pneumoniae. Journal of Bacteriology 94:272–273
    [Google Scholar]
49. Kilian M., Reinholdt J. 1986 Interference with IgA defence mechanisms by extracellular bacterial enzymes. In Medical Microbiology, pp. 173–208 Edited by Easmon C. S. F., Jeljaszewicz J. London: Academic Press;
    [Google Scholar]
50. Krivan H. C, Roberts D. D., Ginsberg V. 1988; Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc-l-4-Gal found in some glycolipids. Proceedings of the National Academy of Sciences of the United States ofAmerica 856157–6161
51. de Kruijff B. 1990; Cholesterol as a target for toxins. Bioscience Reports 10:127–130
    [Google Scholar]
52. Lock R. A., Paton J. C., Hansman D. 1988; Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae. Microbial Pathogenesis 5:461–467
    [Google Scholar]
53. McDaniel L. S., Scott G., Kearney J. F., Briles D. E. 1984; Monoclonal antibodies against protease sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. Journal of Experimental Medicine 160:386–397
    [Google Scholar]
54. McDaniel L. S., Scott G., Widenhofer K., Carroll J., Briles D. E. 1986; Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies. Microbial Pathogenesis 1:519–531
    [Google Scholar]
55. McDaniel L. S., Yother J., Vijayakumar M., McGarry L., Guild W. R. & Briles D. E. 1987; Use of insertional activation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). Journal of Experimental Medicine 165:381–394
    [Google Scholar]
56. McDaniel L. S., Sheffield J. S., Delucchi P., Briles D. E. 1991; PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one serotype. Infection and Immunity 59:222–228
    [Google Scholar]
57. Mengaud J., VlNCENTE M.-F., Chenevert J., Pereira J. M., Geoffroy C, Gicquel-Sanzey B., Baquero F., Perez-Diaz J. C., Cossart P. 1988; Expression in Escherichia coli and sequence analysis of the lysteriolysin O determinant of Listeria monocytogenes. Infection and Immunity 56:766–772
    [Google Scholar]
58. Mengaud J., Vincente M. F. V., Cossart P. 1989; Transcriptional mapping and nucleotide sequence of the Listeria monocytogenes hlyA region reveal structural features that may be involved in regulation. Infection and Immunity 57:3695–3701
    [Google Scholar]
59. Michel E., Reich K. A., Favier R., Berche P., Cossart P. 1990; Attenuated mutants of the intracellular bacterium Listeria monocytogenes obtained by single amino-acid substitutions in listeriolysin O. Molecular Microbiology 4:2167–2178
    [Google Scholar]
60. Mitchell T. J., Mendez F., Paton J. C, Andrew P. W., Boulnois G. J. 1990a; Comparison of pneumolysin genes and proteins from Streptococcus pneumoniae types 1 and 2. Nucleic Acids Research 18:4010
    [Google Scholar]
61. Mitchell T. J., Saunders F. K., Andrew P. W., Boulnois G. J. 1990b Complement activation by pneumolysin, location of domain and similarity to human acute phase protein. In Bacterial Protein Toxins, pp. 101–102 Edited by Rappuoli R. and others. Stuttgart: Gustav Fischer;
    [Google Scholar]
62. Mitchell T. J., Saunders F. K., Smith A. N., Andrew P. W., Boulnois G. J. 1991; Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute phase protein. Molecular Microbiology 5:1883–1888
    [Google Scholar]
63. Mold C, Nakayana S., Holzer T. J., Gewurz H., Du Clos T. W. 1981; C-reactive protein is protective against Streptococcus pneumoniae in mice. Journal of Experimental Medicine 154:1703–1708
    [Google Scholar]
64. Moxon E. R. 1982 Experimental infections of animals in the study of. Streptococcus pneumoniae. In The Pneumococcus and the Pneumococcal Vaccine, pp. 172–175 Edited by Quie P. G., Kass E. H. Chicago: Chicago University Press;
    [Google Scholar]
65. Nohynk H., Teppo A.-M., Laine E., Leinonen M., Eskola J. 1991; Serum tumor necrosis factor-a concentrations in children hospitalized for acute lower respiratory tract infection. Journal of Infectious Diseases 163:1029–1032
    [Google Scholar]
66. Paton J. C., Ferrante A. 1983; Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infection and Immunity 41:1212–1216
    [Google Scholar]
67. Paton J. C, Lock R. A., Hansman D. J. 1983; Effect of immunization with pneumolysin on the survival time of mice challenged Streptococcus pneumoniae. Infection and Immunity 40:548–552
    [Google Scholar]
68. Paton J. C, Rowan-Kelly B., Ferrante A. 1984; Activation of human complement by the pneumococcal toxin pneumolysin. Infection and Immunity 43:1085–1087
    [Google Scholar]
69. Paton J. C, Lock R. A., Lee C.-J., Li J. P., Berry A. M., Mitchell T. J., Andrew P. W., Boulnois G. J. 1991; Purification and immunogenicity of genetically toxoided derivatives of pneumolysin and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infection and Immunity 59:2297–2304
    [Google Scholar]
70. Pinkney M., Beachey E., Kehoe M. 1989; The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infection and Immunity 57:2553–2558
    [Google Scholar]
71. Plotkowski M.-C, Puchelle E., Beck G., Jacquot J., Hannoun C. 1986; Adherence of type 1 Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. American Review of Respiratory Disease 134:1040–1044
    [Google Scholar]
72. Rake G. 1936; Pathology of pneumococcus infection in mice following intranasal instillation. Journal of Experimental Medicine 63:17–31
    [Google Scholar]
73. Rake G. 1937; The rapid invasion of the body through the olfactory mucosa. Journal of Experimental Medicine 65:303–315
    [Google Scholar]
74. Riesenfeld-orn I., Wolpe S., Garcia-Bustos J. F., Hoffmann M. K., Tuomanen E. 1989; Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infection and Immunity 57:1890–1893
    [Google Scholar]
75. Riley I. D., Douglas R. M. 1982 An epidemiological approach to pneumococcal disease. In The Pneumococcus and the Pneumococcal Vaccine, pp. 51–63 Edited by Quie P. G., Kass E. H. Chicago: University of Chicago Press;
    [Google Scholar]
76. Roberts R. B. 1985 Streptococcus pneumoniae. In Principles and Practices of Infectious Diseases, pp. 1142–1152 Edited by Mandell G. L., Douglas R. G., Bennett J. E. New York: Churchill Livingstone;
77. Saunders F. K., Mitchell T. J., Andrew P. W., Boulnois G. J. 1990 Non-essential role for thiol groups in the in vitro activity of pneumolysin, the 'thiol-activated' toxin of Streptococcus pneumoniae. In Bacterial Protein Toxins, pp. 101–102 Edited by Rappuoli R. and others. Stuttgart: Gustav Fischer;
    [Google Scholar]
78. Schulz R. Z., Warren M. F., Drinker C. K. 1938; The passage of rabbit virulent type III pneumococci from the respiratory tract of rabbits into the lymphatics and blood. Journal of Experimental Medicine 68:251–261
    [Google Scholar]
79. Smyth C. J., Duncan J. L. 1978 Thiol-activated (oxygen-labile) cytolysins. In Bacterial Toxins and Cell Membranes, pp. 129–183 Edited by Jeljaszewicz J., Wadstrom T. New York: Academic Press;
    [Google Scholar]
80. Steinfort C, Wilson R., Mitchell T., Feldman C, Rutman A., Todd H., Sykes D., Walker J., Saunders K., Andrew P. W., Boulnois G. J., Cole P. J. 1989; Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infection and Immunity 57:2006–2013
    [Google Scholar]
81. Tanenbaum S. W., Sun S. C. 1971; Some molecular properties of pneumococcal neuraminidase isoenzymes. Biochimica et Biophysica Acta 229:824–828
    [Google Scholar]
82. Tanenbaum S. W., Gulbinsky J., Katz M., Sun S. C. 1970; Separation, purification and some properties of pneumococcal neuraminidase isoenzymes. Biochimica et Biophysica Acta 198:242–254
    [Google Scholar]
83. Tuomanen E., Liu H., Hengstler B., Zak O., &Tomasz A. 1985; The induction of meningeal inflammation by components of the pneumococcal cell wall. Journal of Infectious Diseases 151:859–868
    [Google Scholar]
84. Tuomanen E., Rich R., Zak O. 1987; Induction of pulmonary inflammation by components of the pneumococcal cell wall. American Review of Respiratory Disease 135:869–874
    [Google Scholar]
85. Tweten R. K. 1988; Nucleotide sequence of the gene for perfringolysin O (theta-toxin) from Clostridium perfringens: significant homology with the genes for streptolysin O and pneumolysin. Infection and Immunity 56:3235–3240
    [Google Scholar]
86. Van Epps D. E., Andersen B. R. 1974; Streptolysin O inhibition of neutrophil chemotaxis and mobility: non-immune phenomenon with species specificity. Infection and Immunity 9:27–33
    [Google Scholar]
87. Vazquez-Boland J. A., Dominguez L., Rodriguez-Ferri E. F., Fernandez-Garayzabal J. F., Suarez G. 1989; Preliminary evidence that different domains are involved in cytolytic activity and receptor (cholesterol) binding in listeriolysin O, the Listeria monocytogenes thiol-activated toxin. FEMS Microbiology Letters 65:95–100
    [Google Scholar]
88. Volanakis J. E., Kaplan M. H. 1974; Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human Clq. Journal of Immunology 113:9–17
    [Google Scholar]
89. Walker J. A., Allen R. L., Falmagne P., Johnson M. K., Boulnois G. J. 1987; Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infection and Immunity 55:1184–1189
    [Google Scholar]
90. Wara D. W. 1982 Host defense against. Streptococcus pneumoniae: the role of the spleen In The Pneumococcus and the Pneumococcal Vaccine, pp. 117–127 Edited by Quie P. G., Kass E. H. Chicago: Chicago University Press;
    [Google Scholar]
91. Wllmott R. W., Kassab J. T., Kllian P. L., Benjamin W. R., Douglas S. D., Wood R. E. 1990; Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. American Review of Respiratory Disease 142:365–368
    [Google Scholar]
92. Winkelstein J. A. 1982 The role of complement in the host's defense against. Streptococcus pneumoniae. In The Pneumococcus and the Pneumococcal Vaccine, pp. 107–116 Edited by Quie P. G., Kass E. H. Chicago: Chicago University Press;
    [Google Scholar]
93. Winkelstein J. A. 1984; Complement and the host's defence against the pneumococcus. CRC Critical Reviews in Microbiology 11:187–208
    [Google Scholar]
94. Wright J. K., Tschopp J., Jaton J. C., Engel J. 1980; Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement. Biochemical Journal 187:775–780
    [Google Scholar]
95. Yeagle P. 1987 The Membrane of Cells, p. 292 London: Academic Press;
96. Yother J., Volanakis J. E., Briles D. E. 1982; Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. Journal of Immunology 128:2374–2376
    [Google Scholar]
97. Yother J., McDaniel L. S., Crain M. J., Talkington D. F., Briles D. E. 1991 Pneumococcal surface protein A: structural analysis and biological significance. In Genetics and Molecular Biology of Streptococci, Lactococci, and Enterococci, pp. 88–91 Edited by Dunny G. M., Cleary P. P., McKay L. L. Washington, DC: American Society for Microbiology;
    [Google Scholar]